In an attempt to facilitate stem cell research, two business giant SpineSmith Partners LP joined hands with Whole-body Advanced Vibration Exercise (WAVE). Austin based orthopedic biotech company SpineSmith will sell WAVE’s pre-surgical vibration conditioning technology — effectively introducing the approach to the orthopedic and neurological marketplace.

Recent scientific research indicates the type of vibration process WAVE technology produces, which is similar to vigorous exercise, can improve circulation, reduce pain, and increase flexibility, with minimal stress to joints — and in a fraction of the time of conventional therapies. Increasing circulation helps prepare the surgical site by stimulating the body’s natural healing response and also promotes revascularization and recovery after surgery.

According to Dr. Larry Leigh, Director of Research and Training for WAVE, the company’s vibration therapy helps speed up a patient’s recovery time by recruiting more muscle fibers — thus increasing strength and circulation prior to surgery. Additionally, he says:

“Vibration exercise pre-op may help elevate the quality of cells that are harvested, thus further aiding the body’s healing process.”

The WAVE system uses vibration plates to simulate the body’s natural stretch reflex, recruiting more than 90 percent of muscle fibers to push the body upwards against gravity. WAVE advancements include bringing revolutionary vertical controlled vibration (VCV) technology to the market. Physiological effects on the body include an increase in muscle activity, bone density, and circulation. WAVE whole-body advanced vibration therapy allows patients to achieve the therapeutic benefits of vibration-assisted exercise – but with less stress and friction on joints, ligaments, and tendons than with existing vibration devices.

WAVE has introduced innovations to the market that are quickly making it the preferred vibration platform technology for pre-surgical and post surgical conditioning. Its commitment to providing consistent dosimetry, VCV, and large platform surface area ensures optimal patient safety and product reliability, while maximizing protocol implementation.

Source: MarketWatch